Thérapie par cellules souches

Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSC) in Multiple Sclerosis (MME) with progressive disease status.

Par NBScience, il y a
thérapie par cellules souches